Sharda Cropchem Share Price
660.70+0.00 (-1.54%)
-17.35% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
PIINDNSE
SUMICHEMNSE
BAYERCROPNSE
SHARDACROPNSE
DHANUKANSE
RALLISNSE
NACLINDNSE
BHAGCHEMNSE
GSPCROPNSE
INSECTICIDNSE
Sharda Cropchem Share Price
660.70+0.00 (-1.54%)
-17.35% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 16% | 17% | 9% | 22% |
| 15% | 24% | 26% | 124% |
| 6% | 15% | 17% | -17% |
| 16% | 15% | 13% | 24% |
Peer Comparison
Symbol
PIIND
SUMICHEM
BAYERCROP
SHARDACROP
DHANUKA
RALLIS
NACLIND
BHAGCHEM
GSPCROP
INSECTICID
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,616.4 | ₹24806 Cr | 28.26 | 8.04 | 85.59 | ₹1321 Cr |
| 340.55 | ₹17173 Cr | 30.73 | 3.15 | 12.56 | ₹543 Cr |
| 3,339.4 | ₹15052 Cr | 20.19 | 37.02 | 192.05 | ₹689 Cr |
| 664.6 | ₹6059 Cr | 9.41 | 10.17 | 112.44 | ₹681 Cr |
| 914.85 | ₹4093 Cr | 14.45 | 24.5 | 77.45 | ₹287 Cr |
| 187.9 | ₹3682 Cr | 18.69 | 4.47 | 16.3 | ₹184 Cr |
| 117.5 | ₹2754 Cr | 327.8 | -0.06 | 1.84 | ₹5 Cr |
| 181.1 | ₹2363 Cr | 86.16 | 0.42 | 4.46 | ₹18 Cr |
| 406.4 | ₹1904 Cr | 22.1 | 9.6 | 26.09 | ₹98 Cr |
| 533.1 | ₹1571 Cr | 12.85 | 19.3 | 55.23 | ₹139 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Dec 2016 | Sep 2016 | Jun 2016 | Mar 2016 | Dec 2015 | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 | Mar 2014 | Dec 2013 | Sep 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹1052 Cr | ₹1074 Cr | ₹2065 Cr | ₹1289 Cr | ₹929 Cr | ₹985 Cr | ₹1829 Cr | ₹929 Cr | ₹777 Cr | ₹785 Cr | ₹1312 Cr | ₹632 Cr | ₹581 Cr | ₹638 Cr | ₹1482 Cr | ₹1017 Cr | ₹722 Cr | ₹825 Cr | ₹1435 Cr | ₹880 Cr | ₹643 Cr | ₹623 Cr | ₹1088 Cr | ₹494 Cr | ₹425 Cr | ₹389 Cr | ₹876 Cr | ₹382 Cr | ₹324 Cr | ₹421 Cr | ₹764 Cr | ₹471 Cr | ₹309 Cr | ₹456 Cr | ₹766 Cr | ₹325 Cr | ₹278 Cr | ₹341 Cr | ₹595 Cr | ₹243 Cr | ₹247 Cr | ₹315 Cr | ₹523 Cr | ₹182 Cr | ₹238 Cr | ₹277 Cr | ₹341 Cr | ₹185 Cr | ₹267 Cr | ₹271 Cr | ₹290 Cr | ₹143 Cr | ₹186 Cr |
| ₹45 Cr | ₹35 Cr | ₹22 Cr | ₹21 Cr | ₹29 Cr | ₹32 Cr | ₹36 Cr | ₹62 L | ₹34 Cr | ₹19 Cr | -₹2 Cr | ₹35 Cr | ₹24 Cr | ₹26 Cr | ₹7 Cr | ₹15 Cr | ₹10 Cr | ₹20 Cr | ₹3 Cr | ₹7 Cr | ₹13 Cr | ₹18 Cr | ₹17 Cr | ₹22 Cr | ₹16 Cr | ₹23 Cr | ₹10 Cr | ₹22 Cr | ₹9 Cr | ₹13 Cr | ₹9 Cr | ₹5 Cr | ₹19 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹15 Cr | ₹7 Cr | ₹4 Cr | ₹6 Cr | ₹4 Cr | ₹11 Cr | ₹3 Cr | ₹7 Cr | ₹11 Cr | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹3 Cr | ₹6 Cr | ₹3 Cr |
| ₹1096 Cr | ₹1108 Cr | ₹2087 Cr | ₹1310 Cr | ₹958 Cr | ₹1017 Cr | ₹1864 Cr | ₹930 Cr | ₹811 Cr | ₹804 Cr | ₹1310 Cr | ₹667 Cr | ₹604 Cr | ₹664 Cr | ₹1489 Cr | ₹1032 Cr | ₹732 Cr | ₹845 Cr | ₹1437 Cr | ₹887 Cr | ₹656 Cr | ₹641 Cr | ₹1105 Cr | ₹516 Cr | ₹441 Cr | ₹412 Cr | ₹886 Cr | ₹404 Cr | ₹333 Cr | ₹434 Cr | ₹774 Cr | ₹475 Cr | ₹328 Cr | ₹459 Cr | ₹768 Cr | ₹328 Cr | ₹280 Cr | ₹356 Cr | ₹602 Cr | ₹247 Cr | ₹253 Cr | ₹319 Cr | ₹534 Cr | ₹184 Cr | ₹245 Cr | ₹288 Cr | ₹348 Cr | ₹191 Cr | ₹274 Cr | ₹277 Cr | ₹293 Cr | ₹149 Cr | ₹189 Cr |
| ₹988 Cr | ₹988 Cr | ₹1665 Cr | ₹1131 Cr | ₹872 Cr | ₹848 Cr | ₹1608 Cr | ₹884 Cr | ₹765 Cr | ₹773 Cr | ₹1111 Cr | ₹654 Cr | ₹634 Cr | ₹767 Cr | ₹1231 Cr | ₹888 Cr | ₹717 Cr | ₹826 Cr | ₹1216 Cr | ₹750 Cr | ₹614 Cr | ₹574 Cr | ₹937 Cr | ₹438 Cr | ₹410 Cr | ₹377 Cr | ₹747 Cr | ₹386 Cr | ₹337 Cr | ₹399 Cr | ₹648 Cr | ₹447 Cr | ₹295 Cr | ₹403 Cr | ₹591 Cr | ₹308 Cr | ₹246 Cr | ₹294 Cr | ₹457 Cr | ₹223 Cr | ₹208 Cr | ₹261 Cr | ₹381 Cr | ₹168 Cr | ₹204 Cr | ₹236 Cr | ₹276 Cr | ₹185 Cr | ₹236 Cr | ₹216 Cr | ₹214 Cr | ₹150 Cr | ₹157 Cr |
| ₹209 Cr | ₹221 Cr | ₹510 Cr | ₹262 Cr | ₹162 Cr | ₹248 Cr | ₹328 Cr | ₹115 Cr | ₹115 Cr | ₹96 Cr | ₹253 Cr | ₹82 Cr | ₹45 Cr | -₹33 Cr | ₹325 Cr | ₹210 Cr | ₹75 Cr | ₹73 Cr | ₹293 Cr | ₹195 Cr | ₹103 Cr | ₹121 Cr | ₹220 Cr | ₹119 Cr | ₹73 Cr | ₹71 Cr | ₹174 Cr | ₹52 Cr | ₹29 Cr | ₹70 Cr | ₹163 Cr | ₹52 Cr | ₹53 Cr | ₹75 Cr | ₹195 Cr | ₹38 Cr | ₹52 Cr | ₹77 Cr | ₹164 Cr | ₹37 Cr | ₹57 Cr | ₹71 Cr | ₹163 Cr | ₹24 Cr | ₹48 Cr | ₹62 Cr | ₹78 Cr | ₹11 Cr | ₹44 Cr | ₹66 Cr | ₹86 Cr | ₹7 Cr | ₹39 Cr |
| ₹90 L | ₹2 Cr | ₹47 L | ₹39 L | ₹34 L | ₹56 L | ₹41 L | ₹45 L | ₹48 L | ₹76 L | ₹15 L | ₹90 L | ₹5 Cr | ₹1 Cr | ₹2 Cr | ₹91 L | ₹36 L | ₹76 L | ₹73 L | ₹43 L | ₹44 L | ₹61 L | ₹77 L | ₹45 L | ₹73 L | ₹83 L | ₹45 L | ₹44 L | ₹44 L | ₹59 L | ₹21 L | ₹4 L | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹16 L | ₹7 L | ₹4 L | ₹3 L | ₹20,000 | ₹10,000 | ₹1 L | ₹54 L | ₹40,000 | ₹20,000 | ₹70,000 | ₹0 | ₹57 L | ₹68 L | ₹41 L | ₹52 L | ₹51 L | ₹11 L |
| ₹107 Cr | ₹118 Cr | ₹422 Cr | ₹179 Cr | ₹86 Cr | ₹169 Cr | ₹256 Cr | ₹46 Cr | ₹46 Cr | ₹31 Cr | ₹198 Cr | ₹12 Cr | -₹34 Cr | -₹105 Cr | ₹255 Cr | ₹143 Cr | ₹15 Cr | ₹18 Cr | ₹220 Cr | ₹136 Cr | ₹42 Cr | ₹66 Cr | ₹167 Cr | ₹78 Cr | ₹30 Cr | ₹35 Cr | ₹138 Cr | ₹17 Cr | -₹5 Cr | ₹34 Cr | ₹125 Cr | ₹28 Cr | ₹29 Cr | ₹53 Cr | ₹172 Cr | ₹20 Cr | ₹34 Cr | ₹61 Cr | ₹145 Cr | ₹24 Cr | ₹45 Cr | ₹58 Cr | ₹153 Cr | ₹16 Cr | ₹40 Cr | ₹52 Cr | ₹72 Cr | ₹6 Cr | ₹37 Cr | ₹61 Cr | ₹76 Cr | ₹34 L | ₹32 Cr |
| ₹92 Cr | ₹88 Cr | ₹319 Cr | ₹145 Cr | ₹74 Cr | ₹143 Cr | ₹204 Cr | ₹31 Cr | ₹42 Cr | ₹27 Cr | ₹143 Cr | ₹5 Cr | -₹28 Cr | -₹89 Cr | ₹199 Cr | ₹108 Cr | ₹12 Cr | ₹23 Cr | ₹177 Cr | ₹102 Cr | ₹32 Cr | ₹38 Cr | ₹134 Cr | ₹48 Cr | ₹19 Cr | ₹28 Cr | ₹142 Cr | ₹6 Cr | -₹6 Cr | ₹23 Cr | ₹106 Cr | ₹20 Cr | ₹16 Cr | ₹34 Cr | ₹113 Cr | ₹10 Cr | ₹24 Cr | ₹43 Cr | ₹99 Cr | ₹18 Cr | ₹33 Cr | ₹41 Cr | ₹100 Cr | ₹12 Cr | ₹27 Cr | ₹36 Cr | ₹48 Cr | ₹5 Cr | ₹27 Cr | ₹43 Cr | ₹53 Cr | ₹2 Cr | ₹21 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
| ₹3046 Cr | ₹2410 Cr | ₹2147 Cr | ₹2142 Cr | ₹1822 Cr | ₹1524 Cr | ₹1313 Cr | ₹1194 Cr | ₹1045 Cr | ₹870 Cr | ₹715 Cr | ₹564 Cr | ₹466 Cr | ₹376 Cr | ₹302 Cr | ₹301 Cr | ₹261 Cr | ₹242 Cr |
| ₹3046 Cr | ₹2410 Cr | ₹2147 Cr | ₹2142 Cr | ₹1822 Cr | ₹1524 Cr | ₹1313 Cr | ₹1194 Cr | ₹1045 Cr | ₹870 Cr | ₹715 Cr | ₹564 Cr | ₹466 Cr | ₹376 Cr | ₹302 Cr | ₹301 Cr | ₹261 Cr | ₹242 Cr |
| ₹3136 Cr | ₹2501 Cr | ₹2237 Cr | ₹2232 Cr | ₹1912 Cr | ₹1614 Cr | ₹1403 Cr | ₹1284 Cr | ₹1135 Cr | ₹960 Cr | ₹805 Cr | ₹655 Cr | ₹556 Cr | ₹466 Cr | ₹392 Cr | ₹320 Cr | ₹279 Cr | ₹261 Cr |
| ₹55 L | ₹41 L | ₹38 L | ₹35 L | ₹33 L | ₹31 L | ₹26 L | ₹24 L | ₹24 L | ₹2 L | ₹9 L | ₹3 L | ₹2 L | ₹10,000 | ₹4 L | ₹10,000 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹38,000 | ₹2 L | ₹4 L | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹9 L | ₹9 L | ₹9 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹198 Cr | ₹162 Cr | ₹142 Cr | ₹135 Cr | ₹124 Cr | ₹87 Cr | ₹65 Cr | ₹86 Cr | ₹76 Cr | ₹77 Cr | ₹53 Cr | ₹22 Cr | ₹10 Cr | ₹9 Cr | ₹5 Cr | ₹4 Cr | ₹6 Cr | ₹3 Cr |
| ₹35 Cr | ₹63 Cr | ₹66 Cr | ₹2 Cr | ₹5 Cr | ₹12 Cr | ₹13 Cr | ₹1 Cr | ₹32 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹55 L | ₹90 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹2 Cr | ₹257 Cr | ₹464 Cr | ₹480 Cr | ₹479 Cr | ₹406 Cr | ₹355 Cr | ₹314 Cr | ₹238 Cr | ₹178 Cr | ₹128 Cr | ₹128 Cr | ₹21 L | ₹2 L | ₹2 L | ₹0 | ₹0 | ₹0 |
| ₹236 Cr | ₹482 Cr | ₹672 Cr | ₹617 Cr | ₹610 Cr | ₹507 Cr | ₹435 Cr | ₹404 Cr | ₹317 Cr | ₹256 Cr | ₹181 Cr | ₹149 Cr | ₹10 Cr | ₹9 Cr | ₹5 Cr | ₹4 Cr | ₹6 Cr | ₹3 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹1499 Cr | ₹1310 Cr | ₹921 Cr | ₹1378 Cr | ₹1178 Cr | ₹807 Cr | ₹687 Cr | ₹636 Cr | ₹634 Cr | ₹457 Cr | ₹384 Cr | ₹228 Cr | ₹205 Cr | ₹196 Cr | ₹174 Cr | ₹117 Cr | ₹91 Cr | ₹74 Cr |
| ₹791 Cr | ₹614 Cr | ₹579 Cr | ₹509 Cr | ₹385 Cr | ₹212 Cr | ₹144 Cr | ₹165 Cr | ₹162 Cr | ₹145 Cr | ₹79 Cr | ₹72 Cr | ₹75 Cr | ₹67 Cr | ₹47 Cr | ₹43 Cr | ₹40 Cr | ₹12 Cr |
| ₹0 | ₹0 | ₹3 Cr | ₹3 Cr | ₹38 Cr | ₹68 Cr | ₹0 | ₹0 | ₹170 Cr | ₹24 L | ₹2 Cr | ₹38 Cr | ₹40 Cr | ₹46 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹14 Cr |
| ₹228 Cr | ₹62 Cr | ₹77 Cr | ₹136 Cr | ₹92 Cr | ₹54 Cr | ₹26 Cr | ₹21 Cr | ₹113 Cr | ₹60 Cr | ₹77 Cr | ₹32 Cr | ₹28 Cr | ₹11 Cr | ₹11 Cr | ₹3 Cr | ₹46 L | ₹3 Cr |
| ₹2518 Cr | ₹1986 Cr | ₹1581 Cr | ₹2026 Cr | ₹1693 Cr | ₹1140 Cr | ₹856 Cr | ₹822 Cr | ₹1078 Cr | ₹663 Cr | ₹542 Cr | ₹370 Cr | ₹348 Cr | ₹320 Cr | ₹236 Cr | ₹166 Cr | ₹134 Cr | ₹104 Cr |
| ₹5890 Cr | ₹4969 Cr | ₹4490 Cr | ₹4876 Cr | ₹4216 Cr | ₹3261 Cr | ₹2695 Cr | ₹2510 Cr | ₹2530 Cr | ₹1879 Cr | ₹1529 Cr | ₹1174 Cr | ₹914 Cr | ₹794 Cr | ₹633 Cr | ₹489 Cr | ₹419 Cr | ₹367 Cr |
| ₹18 Cr | ₹101 Cr | ₹146 Cr | ₹75 Cr | ₹75 Cr | ₹74 Cr | ₹74 Cr | ₹55 Cr | ₹11 Cr | ₹72 Cr | ₹42 Cr | ₹49 Cr | ₹35 Cr | ₹44 Cr | ₹47 L | ₹39 L | ₹46 L | ₹21 L |
| ₹0 | ₹0 | ₹3 Cr | ₹3 Cr | ₹38 Cr | ₹68 Cr | ₹9 L | ₹9 L | ₹170 Cr | ₹24 L | ₹2 Cr | ₹38 Cr | ₹40 Cr | ₹46 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹14 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹2818 Cr | ₹2265 Cr | ₹1954 Cr | ₹1674 Cr | ₹1353 Cr | ₹1082 Cr | ₹797 Cr | ₹622 Cr | ₹379 Cr | ₹296 Cr | ₹161 Cr | ₹298 Cr | ₹251 Cr | ₹64 Cr | ₹58 Cr | ₹88 Cr | ₹107 Cr | ₹49 Cr |
| ₹1830 Cr | ₹1514 Cr | ₹1246 Cr | ₹1006 Cr | ₹761 Cr | ₹537 Cr | ₹381 Cr | ₹250 Cr | ₹153 Cr | ₹86 Cr | ₹31 Cr | ₹209 Cr | ₹187 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹989 Cr | ₹750 Cr | ₹708 Cr | ₹668 Cr | ₹592 Cr | ₹544 Cr | ₹416 Cr | ₹372 Cr | ₹226 Cr | ₹210 Cr | ₹130 Cr | ₹88 Cr | ₹64 Cr | ₹64 Cr | ₹58 Cr | ₹88 Cr | ₹107 Cr | ₹49 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹9 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹9 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹83 Cr | ₹338 Cr | ₹559 Cr | ₹571 Cr | ₹556 Cr | ₹477 Cr | ₹425 Cr | ₹366 Cr | ₹276 Cr | ₹227 Cr | ₹173 Cr | ₹164 Cr | ₹20 Cr | ₹14 Cr | ₹8 Cr | ₹3 Cr | ₹3 Cr | ₹61 L |
| ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹119 Cr | ₹3 Cr | ₹9 Cr | ₹11 Cr | ₹4 Cr | ₹29 Cr | ₹15,000 | ₹9 L | ₹0 | ₹8 Cr | ₹7 Cr | ₹3 Cr | ₹3 Cr | ₹9 Cr | ₹9 Cr |
| ₹1321 Cr | ₹1382 Cr | ₹1552 Cr | ₹1562 Cr | ₹1363 Cr | ₹1161 Cr | ₹1014 Cr | ₹962 Cr | ₹891 Cr | ₹670 Cr | ₹513 Cr | ₹410 Cr | ₹231 Cr | ₹179 Cr | ₹136 Cr | ₹131 Cr | ₹141 Cr | ₹90 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹361 Cr | ₹294 Cr | ₹159 Cr | ₹32 Cr | ₹134 Cr | ₹83 Cr | ₹116 Cr | ₹212 Cr | ₹22 Cr | ₹61 Cr | ₹90 Cr | ₹86 Cr | ₹169 Cr | ₹92 Cr | ₹32 Cr | ₹25 Cr | ₹17 Cr | ₹37 Cr |
| ₹1120 Cr | ₹972 Cr | ₹992 Cr | ₹1134 Cr | ₹893 Cr | ₹526 Cr | ₹382 Cr | ₹365 Cr | ₹530 Cr | ₹288 Cr | ₹160 Cr | ₹140 Cr | ₹81 Cr | ₹93 Cr | ₹102 Cr | ₹58 Cr | ₹38 Cr | ₹21 Cr |
| ₹2389 Cr | ₹1955 Cr | ₹1498 Cr | ₹1833 Cr | ₹1540 Cr | ₹1163 Cr | ₹989 Cr | ₹811 Cr | ₹892 Cr | ₹673 Cr | ₹620 Cr | ₹454 Cr | ₹400 Cr | ₹377 Cr | ₹326 Cr | ₹248 Cr | ₹214 Cr | ₹211 Cr |
| ₹220 Cr | ₹220 Cr | ₹88 Cr | ₹177 Cr | ₹166 Cr | ₹261 Cr | ₹153 Cr | ₹124 Cr | ₹101 Cr | ₹108 Cr | ₹65 Cr | ₹70 Cr | ₹22 Cr | ₹36 Cr | ₹30 Cr | ₹23 Cr | ₹7 Cr | ₹6 Cr |
| ₹82 Cr | ₹52 Cr | ₹56 Cr | ₹46 Cr | ₹63 Cr | ₹67 Cr | ₹32 Cr | ₹28 Cr | ₹11 Cr | ₹18 Cr | ₹5 Cr | ₹3 Cr | ₹5 Cr | ₹3 Cr | ₹78 L | ₹67 L | ₹89 L | ₹84 L |
| ₹398 Cr | ₹92 Cr | ₹146 Cr | ₹92 Cr | ₹57 Cr | ₹1 Cr | ₹9 Cr | ₹9 Cr | ₹83 Cr | ₹62 Cr | ₹76 Cr | ₹11 Cr | ₹7 Cr | ₹15 Cr | ₹6 Cr | ₹3 Cr | ₹89 L | ₹68 L |
| ₹4570 Cr | ₹3586 Cr | ₹2938 Cr | ₹3314 Cr | ₹2853 Cr | ₹2100 Cr | ₹1681 Cr | ₹1548 Cr | ₹1639 Cr | ₹1209 Cr | ₹1015 Cr | ₹764 Cr | ₹683 Cr | ₹616 Cr | ₹497 Cr | ₹359 Cr | ₹278 Cr | ₹277 Cr |
| ₹2052 Cr | ₹1601 Cr | ₹1357 Cr | ₹1288 Cr | ₹1160 Cr | ₹960 Cr | ₹825 Cr | ₹727 Cr | ₹561 Cr | ₹546 Cr | ₹473 Cr | ₹394 Cr | ₹335 Cr | ₹296 Cr | ₹262 Cr | ₹193 Cr | ₹144 Cr | ₹173 Cr |
| ₹5890 Cr | ₹4969 Cr | ₹4490 Cr | ₹4876 Cr | ₹4216 Cr | ₹3261 Cr | ₹2695 Cr | ₹2510 Cr | ₹2530 Cr | ₹1879 Cr | ₹1529 Cr | ₹1174 Cr | ₹914 Cr | ₹794 Cr | ₹633 Cr | ₹489 Cr | ₹419 Cr | ₹367 Cr |
| ₹348 | ₹277 | ₹248 | ₹247 | ₹212 | ₹179 | ₹155 | ₹142 | ₹126 | ₹106 | ₹89 | ₹73 | ₹62 | ₹52 | ₹43 | ₹177 | ₹155 | ₹144 |
| ₹348 | ₹277 | ₹248 | ₹247 | ₹212 | ₹179 | ₹155 | ₹142 | ₹126 | ₹106 | ₹89 | ₹73 | ₹62 | ₹52 | ₹43 | ₹35 | ₹31 | ₹29 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Cash & Cash Equivalent of Subsidiaries under liquidations
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹856 Cr | ₹378 Cr | ₹72 Cr | ₹431 Cr | ₹464 Cr | ₹309 Cr | ₹185 Cr | ₹235 Cr | ₹287 Cr | ₹272 Cr | ₹261 Cr | ₹176 Cr | ₹157 Cr | ₹117 Cr | ₹86 Cr | ₹51 Cr | ₹35 Cr | ₹76 Cr |
| ₹319 Cr | ₹287 Cr | ₹273 Cr | ₹267 Cr | ₹257 Cr | ₹163 Cr | ₹194 Cr | ₹147 Cr | ₹85 Cr | ₹41 Cr | ₹8 Cr | ₹4 Cr | ₹29 Cr | ₹40 Cr | ₹43 Cr | ₹33 Cr | ₹39 Cr | ₹8 Cr |
| -₹454 Cr | -₹31 Cr | ₹47 Cr | -₹304 Cr | -₹379 Cr | -₹168 Cr | -₹170 Cr | ₹255 Cr | -₹276 Cr | -₹75 Cr | -₹3 Cr | -₹72 Cr | ₹12 Cr | -₹34 Cr | -₹62 Cr | -₹19 Cr | -₹15 Cr | -₹36 Cr |
| ₹721 Cr | ₹635 Cr | ₹392 Cr | ₹394 Cr | ₹342 Cr | ₹304 Cr | ₹209 Cr | ₹637 Cr | ₹97 Cr | ₹238 Cr | ₹266 Cr | ₹107 Cr | ₹198 Cr | ₹124 Cr | ₹66 Cr | ₹66 Cr | ₹59 Cr | ₹48 Cr |
| ₹656 Cr | ₹604 Cr | ₹341 Cr | ₹328 Cr | ₹267 Cr | ₹246 Cr | ₹146 Cr | ₹556 Cr | ₹17 Cr | ₹181 Cr | ₹197 Cr | ₹46 Cr | ₹156 Cr | ₹84 Cr | ₹39 Cr | ₹55 Cr | ₹51 Cr | ₹36 Cr |
| -₹513 Cr | -₹510 Cr | -₹393 Cr | -₹145 Cr | -₹208 Cr | -₹282 Cr | -₹68 Cr | -₹360 Cr | -₹163 Cr | -₹104 Cr | -₹120 Cr | -₹22 Cr | -₹151 Cr | -₹113 Cr | -₹47 Cr | -₹37 Cr | -₹29 Cr | -₹81 Cr |
| -₹118 Cr | -₹68 Cr | -₹37 Cr | -₹97 Cr | -₹91 Cr | ₹43 Cr | -₹60 Cr | -₹215 Cr | ₹132 Cr | -₹38 Cr | -₹89 Cr | -₹24 Cr | -₹22 Cr | ₹32 Cr | -₹39 L | -₹5 L | -₹12 Cr | ₹36 Cr |
| ₹24 Cr | ₹26 Cr | -₹89 Cr | ₹86 Cr | -₹32 Cr | ₹8 Cr | ₹19 Cr | -₹19 Cr | -₹14 Cr | ₹40 Cr | -₹12 Cr | ₹3 L | -₹16 Cr | ₹3 Cr | -₹8 Cr | ₹18 Cr | ₹10 Cr | -₹9 Cr |
| ₹127 Cr | ₹87 Cr | ₹176 Cr | ₹57 Cr | ₹86 Cr | ₹78 Cr | ₹51 Cr | ₹61 Cr | ₹72 Cr | ₹32 Cr | ₹38 Cr | ₹22 Cr | ₹32 Cr | ₹30 Cr | ₹23 Cr | ₹7 Cr | ₹6 Cr | ₹49 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹3 Cr | ₹0 | ₹3 L | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹17 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹68 Cr | ₹14 Cr | ₹8 L | ₹34 Cr | ₹3 Cr | -₹34 L | ₹8 Cr | ₹8 Cr | ₹3 Cr | -₹16 L | ₹7 Cr | ₹3 Cr | ₹3 Cr | -₹9 L | ₹15 Cr | -₹2 Cr | -₹10 Cr | ₹15 Cr |
| ₹220 Cr | ₹127 Cr | ₹87 Cr | ₹176 Cr | ₹57 Cr | ₹86 Cr | ₹78 Cr | ₹51 Cr | ₹61 Cr | ₹72 Cr | ₹32 Cr | ₹25 Cr | ₹22 Cr | ₹32 Cr | ₹30 Cr | ₹23 Cr | ₹7 Cr | ₹6 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Sharda Cropchem Share Price
660.70+0.00 (-1.54%)
-17.35% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 6 out of 9 oscillators
RSI
38.83Sell
STOCH %K
3.41Buy
MACD Level(12,26)
-4.88Sell
Ultimate Oscillator
40.59Sell
Aroon Oscillator
-62.00Sell
BOP
-0.57Sell
CCI
-76.71Neutral
Williams %R
-96.59Buy
Momentum
-24.10Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
691.78Sell
SMA 9
704.29Sell
EMA 21
695.39Sell
SMA 21
684.55Sell
EMA 50
718.04Sell
SMA 50
712.57Sell
EMA 200
821.83Sell
SMA 200
900.98Sell
WMA 20
694.47Sell
Pivot
Pivot
Classic
Resistance 5
812.03
Resistance 4
778.78
Resistance 3
745.53
Resistance 2
712.28
Resistance 1
691.67
Pivot
679.03
Support 1
658.42
Support 2
645.78
Support 3
612.53
Support 4
579.28
Support 5
546.03
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Sharda Cropchem Share Price
660.70+0.00 (-1.54%)
-17.35% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% |
| 3.27% | 3.12% | 4.60% | 4.20% | 5.26% | 5.48% |
| 0.31% | 0.30% | 0.46% | 0.44% | 0.17% | 0.05% |
| 8.91% | 8.88% | 9.24% | 9.51% | 9.09% | 9.33% |
| 12.69% | 12.88% | 10.88% | 11.03% | 10.66% | 10.32% |
Bulk & block deals
Name
Graviton Research Capital Llp
Hrti Private Limited
Hrti Private Limited
Graviton Research Capital Llp
Xtx Markets Llp
Xtx Markets Llp
Goldman Sachs India Fund Limited
Goldman Sachs India Limited
Hdfc Mf Prudence Fd
Hdfc Mf Prudence Fd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 28 Jul 2025 | Purchase | 78.36 Cr | ₹1,111.31 | 7.05 L | Bulk | 0.781571 | NSE |
| 28 Jul 2025 | Purchase | 50.04 Cr | ₹1,108 | 4.52 L | Bulk | 0.50056 | NSE |
| 28 Jul 2025 | Sell | 49.02 Cr | ₹1,110.57 | 4.41 L | Bulk | 0.489246 | NSE |
| 28 Jul 2025 | Sell | 78.35 Cr | ₹1,111.15 | 7.05 L | Bulk | 0.781571 | NSE |
| 24 Jan 2022 | Purchase | 19.88 Cr | ₹433.39 | 4.59 L | Bulk | 0.508308 | NSE |
| 24 Jan 2022 | Sell | 19.89 Cr | ₹434 | 4.58 L | Bulk | 0.507946 | NSE |
| 07 Jun 2018 | Sell | 27.41 Cr | ₹400.09 | 6.85 L | Bulk | 0.759251 | BSE |
| 07 Jun 2018 | Sell | 27.40 Cr | ₹400.04 | 6.85 L | Bulk | 0.759251 | NSE |
| 25 Sep 2014 | Purchase | 22.42 Cr | ₹262.18 | 8.55 L | Bulk | 0.947678 | NSE |
| 24 Sep 2014 | Purchase | 23.44 Cr | ₹241.64 | 9.70 L | Bulk | 1.075144 | NSE |
Insider trading & SAST
Client name
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|
Sharda Cropchem Share Price
660.70+0.00 (-1.54%)
-17.35% past 1 Year
Sharda Cropchem Limited is principally engaged in export of agrochemicals (technical grade and formulations) and non-agro products such as conveyor belts, rubber belts/sheets, dyes & dye intermediates and general chemicals
Corporate Actions
Date
Type
Details
Company details
Sharda Cropchem Share Price
660.70+0.00 (-1.54%)
-17.35% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Sharda Cropchem Share Price
660.70+0.00 (-1.54%)
-17.35% past 1 Year
News
1 of 20
ResultSHARDACROP30 Oct 2026
Sharda Cropchem reported second-quarter EBITDA of Rs 164 crores, up from Rs 133 crores in the corresponding year-ago quarter, indicating year-on-year growth of approximately 23.3%. EBITDA margin improved to 15.6% from 14.3%, reflecting a 130 basis point expansion. Revenue and PAT figures, sequential comparisons, management commentary, and market reaction were not provided. The company operates in the pesticides and agrochemicals industry.
Sharda Cropchem Reports Strong Year On Year Revenue Growth In Second Quarter
ResultSHARDACROP30 Oct 2026
Sharda Cropchem reported second-quarter revenue of Rs 1,050.00 crores, compared with Rs 930.00 crores in the corresponding quarter a year earlier, representing year-on-year growth of approximately 12.9%. The available update does not provide EBITDA, PAT, operating margin, net margin, sequential revenue, or management guidance. Consequently, profitability trends and quarter-on-quarter performance cannot be assessed from the disclosed information. The company operates in the pesticides and agrochemicals segment and is listed on NSE under the symbol SHARDACROP. The revenue increase indicates stronger business activity compared with the year-ago period, while the absence of earnings and margin details limits assessment of the overall result quality.
Sharda Cropchem Reports Strong Second Quarter Consolidated Profit Growth
ResultSHARDACROP30 Oct 2026
Sharda Cropchem reported consolidated net profit of Rs 91.80 crores for the second quarter, compared with Rs 74.30 crores in the corresponding quarter of the previous year, representing year-on-year growth of approximately 23.55 percent. Revenue, EBITDA, operating margin, net margin, quarter-on-quarter performance, and street expectations were not provided in the available information and have therefore not been included.
The result indicates improved profitability on a year-on-year basis for the pesticides and agrochemicals company. No management guidance or market reaction was provided. The company is listed on NSE under the symbol SHARDACROP and has ISIN INE221J01015.
Sharda Cropchem Q1 FY27 revenue rises strongly year on year
ResultSHARDACROP29 Jul 2026
Sharda Cropchem has reported a healthy year on year improvement in revenue for the latest reported quarter. Q1 revenue came in at Rs 1074.00 crores compared with Rs 985.00 crores in the corresponding quarter last year, indicating a solid increase in top line performance. This growth suggests improved demand or better realisation in its core agrochemicals and related businesses, and points to an expansion in volumes, pricing, or product mix compared to the previous year’s first quarter. The reported numbers reflect a positive operational trend for the company’s revenue base in the current financial year.
Key profitability metrics such as EBITDA, PAT, and margin trends are not provided in the available context, and therefore cannot be assessed. Similarly, quarter on quarter comparisons, detailed segmental performance, or geographic revenue splits are not disclosed. There is no information on street expectations, consensus estimates, or any management commentary, so it is not possible to compare the reported revenue against market forecasts or to infer any change in strategic guidance. The context also does not include data on stock price reaction, movement in market capitalisation, or changes in analyst ratings following the result announcement.
Within these constraints, the main verifiable takeaway is that Sharda Cropchem has delivered higher Q1 revenue year on year, which is generally viewed as a constructive operational outcome for an equity investor tracking the company’s growth trajectory in the Indian markets.
Sharda Cropchem Q1 EBITDA declines with compression in operating margin YoY
ResultSHARDACROP29 Jul 2026
Sharda Cropchem has reported a year-on-year decline in operating performance for the latest Q1 results. Q1 EBITDA stands at Rs 186.00 crores, lower than Rs 215.00 crores reported in the same quarter last year, indicating a contraction in absolute operating earnings on a YoY basis. This points to weaker operating profitability compared to the prior-year quarter, even though detailed revenue and PAT figures are not available in the given context.
The Q1 EBITDA margin has also softened, coming in at 17.32 percent versus 21.86 percent in the corresponding quarter last year. This margin compression suggests that cost pressures, pricing, or product mix changes have adversely affected operating efficiency and profitability. Without explicit revenue data, the exact drivers of margin movement cannot be quantified, but the decline in both EBITDA and EBITDA margin clearly reflects a less favourable operating environment relative to the prior-year period.
The absence of information on revenue, PAT, and street expectations limits a complete assessment of overall financial health and market positioning for this quarter. Similarly, there is no visibility on management commentary, forward guidance, or specific regional and product segment performance. However, from an earnings standpoint, the reported figures indicate that Sharda Cropchem has faced operational headwinds in Q1, as evidenced by lower EBITDA and a notable narrowing of margins. Any market reaction or stock price movement is not provided in the available context, so the immediate trading impact cannot be assessed. Nonetheless, on a standalone basis, the data signals a weaker operating quarter compared with the same period last year.
Sharda Cropchem Q1 FY earnings show sharp year-on-year profit decline
ResultSHARDACROP29 Jul 2026
Sharda Cropchem has reported its consolidated net profit for the latest Q1 period at Rs 88.00 crores, compared with Rs 140.00 crores in the same quarter last year. This indicates a substantial year-on-year decline in profitability in absolute terms. The available context only specifies consolidated net profit (PAT), and no verifiable data on revenue, EBITDA, margins or quarter-on-quarter performance is provided within the current validated window. As a result, the analysis must remain focused strictly on the profit figure disclosed.
With profit falling from Rs 140.00 crores to Rs 88.00 crores, Sharda Cropchem appears to have faced headwinds affecting its earnings trajectory on an annual comparison basis. The magnitude of decline suggests pressure on operating performance or other profit drivers; however, in the absence of confirmed details on revenue trends, operating expenses, or finance costs, it is not possible to attribute the decline to specific line items without introducing unverifiable assumptions. There is also no mention of street expectations, consensus estimates, or management guidance in the provided context, so no inference can be made regarding whether the reported numbers were above or below market expectations.
The information set does not include net or operating margin data, commentary on demand conditions in key geographies, or any indication of changes in product mix, currency effects, or input costs that might have influenced profitability. Similarly, there is no reliable update on stock price reaction, intraday volatility, or changes in trading volumes for SHARDACROP following the result announcement, preventing any evidence-based linkage between the earnings release and immediate market behavior. Given these constraints, the summary is confined to the verified Q1 consolidated net profit figure and its year-on-year decline, without extending into speculative drivers or sentiment-linked narratives.
Sharda Cropchem warns of higher China-linked input costs and price hikes ahead
Stock NewsSHARDACROP3 Jun 2026
Sharda Cropchem has indicated that it expects a significant rise in procurement costs, primarily due to higher prices of key raw materials that are largely sourced from China. The company relies extensively on Chinese suppliers for a substantial portion of its agrochemical and chemical intermediates, making its cost base sensitive to any disruption, price inflation, or policy changes in that geography. Management now anticipates that the current cost escalation trend will necessitate upward revisions in selling prices across a meaningful part of its product portfolio.
As a direct response to the sustained increase in input costs, Sharda Cropchem is looking at potential price increases in the range of about 10-15 percent on selected products and markets. The pass-through of cost inflation via higher realizations is aimed at protecting operating margins and preserving profitability, although the exact extent of margin protection will depend on competitive dynamics and customer acceptance of revised prices. For channel partners and end customers, this could translate into higher procurement costs for crop protection solutions in the near term, particularly where alternative sourcing options are limited.
From an earnings perspective, the development underscores rising input-cost pressure and the company’s pricing power to partially mitigate it through calibrated price hikes. A 10-15 percent increase in product prices, if successfully implemented without substantial loss of volumes, can help offset a large part of the procurement cost increase and support revenue growth in value terms. However, higher selling prices also introduce some risk of demand elasticity and potential down-trading, especially in price-sensitive markets. Investors and traders in SHARDACROP will closely monitor how effectively the company executes these price increases, the response from competitors that may also be China-dependent, and any further signals on supply-chain stability from China.
Sharda Cropchem passes on higher freight costs, expects margin recovery in Q1
Stock NewsSHARDACROP3 Jun 2026
Sharda Cropchem is in focus after management commentary indicating that the company has successfully transferred increased freight costs to its customers. This development suggests that despite a challenging cost environment, particularly on the logistics side, Sharda Cropchem has been able to protect its pricing power and avoid a sharp margin squeeze by passing on a significant portion of the cost escalation. The ability to renegotiate terms with customers and adjust selling prices in response to higher freight outgo is strategically important for preserving operating profitability in an inflationary input-cost backdrop.
The company also indicated that a recovery is expected in the upcoming Q1, which implies management is anticipating an improvement in operational performance versus the recent weak phase driven by elevated freight and logistics expenses. The expected recovery could stem from a combination of normalizing freight rates, better product-mix, and the lagged benefit of price hikes taken to offset cost pressures. For investors, this signals that the worst of the margin pressure from freight inflation may be behind the company, with Q1 likely to show sequential improvement in profitability metrics if demand conditions remain stable.
From an earnings perspective, the pass-through of higher freight costs, if sustained, should help Sharda Cropchem limit erosion in EBITDA margins relative to what would have occurred had the company absorbed these costs fully. Over the medium term, the trajectory of freight rates and the company’s ability to maintain customer relationships while enforcing higher realizations will be key variables for earnings visibility. While no specific quantum in terms of revenue, volume growth, or profit impact has been disclosed in this news snippet, the directional commentary on cost pass-through and expected Q1 recovery is relevant for market participants tracking the stock’s margin resilience and near-term earnings trajectory.
Sharda Cropchem - Quaterly Results
ResultSHARDACROP13 May 2026
NULL
Sharda Cropchem Reports Strong Q4 EBITDA Growth to Rs 487 Cr, Margin at 23.6%
ResultSHARDACROP13 May 2026
Sharda Cropchem announced robust Q4 results with EBITDA surging to Rs 487.00 crores, up from Rs 303.00 crores in the year-ago quarter (YoY). The EBITDA margin expanded significantly to 23.6% from 16.58% YoY, reflecting improved operational efficiency and profitability.
This strong performance underscores the company's resilience in the agrochemical sector amid favorable market conditions. No details on revenue, PAT, or QoQ comparisons were provided in the update. Street expectations or management guidance remain unmentioned.
Sharda Cropchem Reports Q4 Revenue Growth to Rs 2060 Crores, Up from Rs 1830 Crores YoY
ResultSHARDACROP13 May 2026
Sharda Cropchem announced its Q4 financial results, recording revenue of Rs 2060.00 crores, marking an increase from Rs 1830.00 crores in the year-ago quarter. This YoY growth reflects improved top-line performance for the agrochemical company listed on NSE/BSE under the symbol SHARDACROP.
The results highlight a 12.57% rise in revenue, calculated as the difference between Rs 2060 crores and Rs 1830 crores. No details on EBITDA, PAT, margins, or comparisons to street expectations were provided in the available context. Additional metrics such as QoQ changes or management guidance remain unavailable.
This earnings update falls under the equity category, specifically corporate results, underscoring Sharda Cropchem's operational progress in the quarter.
Sharda Cropchem Q4 Consolidated Net Profit Rises 57% YoY to Rs 320 Crores
ResultSHARDACROP13 May 2026
Sharda Cropchem reported its Q4 consolidated net profit at Rs 320.00 crores, marking a significant year-on-year increase from Rs 204.00 crores in the previous year's corresponding quarter. This represents a growth of approximately 57%, highlighting robust performance in the quarter.
The earnings disclosure falls under the corporate results category for the equity segment, specifically for the symbol SHARDACROP on NSE/BSE. No details on revenue, EBITDA, or margin trends were provided in the available context. Street expectations or consensus figures are not mentioned. Management commentary or forward guidance is absent from the report.
This result underscores strong profitability momentum for the agrochemical company amid its operations in the sector.
Sharda Cropchem reports Profit after tax of 352.40 Crores, in the March 2026 quarter
ResultSHARDACROP13 May 2026
NULL
Sharda Cropchem Raises EBITDA Margin Guidance to 18-20% From 15-18%
Stock NewsSHARDACROP30 Jan 2026
Sharda Cropchem Ltd has raised its EBITDA margin guidance for FY26 to 18-20%, closer to 20%, from the earlier projection of 15-18%, signaling management confidence in sustained operational improvement and margin expansion. The upgrade follows strong operational performance driven by global demand revival, pricing recovery, and stabilized input costs.
Key Financial Highlights:
• Q3 FY26 Revenue surged 38.68% YoY to Rs 1,288.76 crores, with nine-month FY26 consolidated net sales reaching Rs 3,202.68 crores (up 27.57% YoY)
• Q3 EBITDA reached Rs 245.5 crores with margins improving to 18.70%, up 638 basis points YoY—highest quarterly operating margin since June 2025
• Profit After Tax (PAT) surged 365.87% YoY in Q3 to Rs 145 crores, with PAT margin expanding 791 basis points to 11.26%
• Gross margin recovered to 34.5% in Q2 and 20.32% in Q3, supported by stabilized raw material costs and favorable regional product mix, particularly strong margins in Europe
• Nine-month ROCE stands at impressive 20.85%, with Q3 ROCE surging to 24.83%
• Balance sheet remains strong with approximately Rs 790 crore in cash and zero debt
Management Outlook: Chairman Ramprakash Bubna attributed strong performance to normalization of global agrochemical inventory levels, stable euro-dollar exchange rates (critical given 95% dollar-denominated sourcing and majority European sales), and operational efficiencies. Management expects to sustain growth momentum barring adverse geopolitical developments. FY26 full-year revenue expected to grow around 20%. The company maintains a debt-free status with promoter holding of 74.80% and market cap of Rs 7,700 crore.
Key Financial Highlights:
• Q3 FY26 Revenue surged 38.68% YoY to Rs 1,288.76 crores, with nine-month FY26 consolidated net sales reaching Rs 3,202.68 crores (up 27.57% YoY)
• Q3 EBITDA reached Rs 245.5 crores with margins improving to 18.70%, up 638 basis points YoY—highest quarterly operating margin since June 2025
• Profit After Tax (PAT) surged 365.87% YoY in Q3 to Rs 145 crores, with PAT margin expanding 791 basis points to 11.26%
• Gross margin recovered to 34.5% in Q2 and 20.32% in Q3, supported by stabilized raw material costs and favorable regional product mix, particularly strong margins in Europe
• Nine-month ROCE stands at impressive 20.85%, with Q3 ROCE surging to 24.83%
• Balance sheet remains strong with approximately Rs 790 crore in cash and zero debt
Management Outlook: Chairman Ramprakash Bubna attributed strong performance to normalization of global agrochemical inventory levels, stable euro-dollar exchange rates (critical given 95% dollar-denominated sourcing and majority European sales), and operational efficiencies. Management expects to sustain growth momentum barring adverse geopolitical developments. FY26 full-year revenue expected to grow around 20%. The company maintains a debt-free status with promoter holding of 74.80% and market cap of Rs 7,700 crore.
Sharda Cropchem - Quaterly Results
ResultSHARDACROP29 Jan 2026
NULL
Sharda Cropchem informs about record date
Stock NewsSHARDACROP29 Jan 2026
NULL
Sharda Cropchem Reports Strong Q3 FY25 EBITDA Growth to Rs 163 Cr, Margin at 12.59%.
ResultSHARDACROP29 Jan 2026
Sharda Cropchem announced robust Q3 FY25 results with **EBITDA at Rs 163 crores**, up from Rs 115 crores YoY, and **EBITDA margin expanding to 12.59%** from 12.34% YoY. Consolidated revenue surged 47% YoY to Rs 929.3 crores from Rs 632.5 crores, driven by 49.1% overall volume growth, with agrochemical volumes up 49.5% and segment revenue rising 51% to Rs 769 crores. Non-agrochemical segment revenue grew 30% YoY to Rs 160 crores.
Gross profit increased 84% to Rs 304.2 crores with margin improving to 32.7% from 26.2%, aided by stabilized raw material prices. EBITDA reached Rs 156.6-163 crores (per reports), reflecting 232% YoY growth from Rs 47 crores, with margin at 16.9%. PAT stood at Rs 31.1 crores, up from Rs 4.6 crores YoY. For 9M FY25, revenue grew 35% to Rs 2,491 crores, EBITDA at Rs 330 crores (13.2% margin), and PAT at Rs 100.8 crores versus loss of Rs 111.6 crores last year.
Regional growth was strong: NAFTA up 95%, LATAM 65%, Europe 22%. Capex for 9M at Rs 268 crores, targeting Rs 400-450 crores for FY25. Company remains net debt-free with Rs 742 crores in cash and equivalents, working capital days improved to 98.
Gross profit increased 84% to Rs 304.2 crores with margin improving to 32.7% from 26.2%, aided by stabilized raw material prices. EBITDA reached Rs 156.6-163 crores (per reports), reflecting 232% YoY growth from Rs 47 crores, with margin at 16.9%. PAT stood at Rs 31.1 crores, up from Rs 4.6 crores YoY. For 9M FY25, revenue grew 35% to Rs 2,491 crores, EBITDA at Rs 330 crores (13.2% margin), and PAT at Rs 100.8 crores versus loss of Rs 111.6 crores last year.
Regional growth was strong: NAFTA up 95%, LATAM 65%, Europe 22%. Capex for 9M at Rs 268 crores, targeting Rs 400-450 crores for FY25. Company remains net debt-free with Rs 742 crores in cash and equivalents, working capital days improved to 98.
Sharda Cropchem reports Profit after tax of 167.21 Crores, in the December 2025 quarter
ResultSHARDACROP29 Jan 2026
NULL
Sharda Cropchem Reports Q3 FY25 Revenue of Rs 1300 Cr, Up 40% YoY.
ResultSHARDACROP29 Jan 2026
Sharda Cropchem announced Q3 FY25 results with consolidated revenue at approximately Rs 930 crores, up 47% YoY from Rs 632 crores in Q3 FY24. This reflects strong volume growth of 49% YoY, driven by agrochemical segment (Rs 769 crores, +51% YoY) and non-agrochemical segment (Rs 160 crores, +30% YoY). Key regions include Europe, LatAm, and NAFTA.
Gross margins expanded 660 basis points to 32.7% from 26.2% YoY, aided by stabilizing raw material prices. EBITDA surged 232% YoY to Rs 157 crores (margin 16.9%), while PAT rose to Rs 31.14 crores from Rs 4.63 crores YoY. For 9M FY25, revenue grew 35% to Rs 2,526 crores, EBITDA at Rs 330 crores (13.2% margin), and PAT turned positive at Rs 100.81 crores versus loss of Rs 111.58 crores prior year.
Company remains net debt-free with Rs 742 crores in cash and equivalents, working capital days improved to 98. Capex for 9M FY25 at Rs 268 crores, full year guidance Rs 400-450 crores. Management highlights best Q3 in history with momentum expected into Q4 FY25 and FY26.
Sharda Cropchem Reports Q3 FY25 Consolidated Net Profit of Rs 145 Cr, Up Significantly YoY.
ResultSHARDACROP29 Jan 2026
Sharda Cropchem announced Q3 FY25 results with consolidated net profit at Rs 145 crores, markedly higher than Rs 31.10 crores in Q3 FY24. Total revenue reached Rs 929.94 crores, reflecting 47% YoY growth from Rs 632 crores, driven by 49% volume growth primarily in agrochemicals (up 51% to Rs 769 crores) and non-agrochemicals (up 30% to Rs 160 crores). Gross margin improved to 32.7% from 26.2% YoY, a 660 bps expansion due to stabilizing raw material costs.
EBITDA surged 232% YoY to Rs 157 crores with margin at 16.9% (from Rs 47 crores). For 9M FY25, revenue grew 35% to Rs 2,526 crores, EBITDA to Rs 330 crores (13.2% margin), and PAT swung to Rs 101 crores from loss of Rs 112 crores YoY. The company remains net debt-free with Rs 742 crores in cash and equivalents, working capital days improved to 98 from 158. Management highlighted this as the best Q3 in history, expecting momentum into Q4 FY25 and FY26, with FY25 CapEx at Rs 400-450 crores.

